See more : Strateco Resources Inc. (SRSIF) Income Statement Analysis – Financial Results
Complete financial analysis of SeaStar Medical Holding Corporation (ICU) income statement, including revenue, profit margins, EPS and key performance metrics. Get detailed insights into the financial performance of SeaStar Medical Holding Corporation, a leading company in the Biotechnology industry within the Healthcare sector.
You may be interested
- Keppel Corporation Limited (KPELY) Income Statement Analysis – Financial Results
- Som Distilleries & Breweries Limited (SDBL.BO) Income Statement Analysis – Financial Results
- Leonovus Inc. (LVNSF) Income Statement Analysis – Financial Results
- Macarthur Minerals Limited (MMS.V) Income Statement Analysis – Financial Results
- Gage Growth Corp. (GAEGF) Income Statement Analysis – Financial Results
SeaStar Medical Holding Corporation (ICU)
About SeaStar Medical Holding Corporation
SeaStar Medical Holding Corporation, a medical device company, focuses on providing novel solutions and services to treat hyperinflammation and cytokine storm in critically ill patients. The company is developing and commercializing extracorporeal therapies that target the effector cells that drive systemic inflammation, causing direct tissue damage and secreting a range of pro-inflammatory cytokines that initiate and propagate imbalanced immune responses. It is developing products in various therapeutic areas, including pediatric and adult acute kidney injury on CRRT; cardiorenal syndrome in congestive heart failure with and without LVAD; myocardial stunning in end stage renal disease; and hepatorenal syndrome. The company is based in Denver, Colorado.
| Metric | 2023 | 2022 | 2021 | 2020 |
|---|---|---|---|---|
| Revenue | 0.00 | 0.00 | 0.00 | 0.00 |
| Cost of Revenue | 0.00 | 0.00 | 0.00 | 0.00 |
| Gross Profit | 0.00 | 0.00 | 0.00 | 0.00 |
| Gross Profit Ratio | 0.00% | 0.00% | 0.00% | 0.00% |
| Research & Development | 5.97M | 2.82M | 2.77M | 4.03M |
| General & Administrative | 8.01M | 6.60M | 1.68M | 2.43M |
| Selling & Marketing | 32.00K | 0.00 | 0.00 | 0.00 |
| SG&A | 8.04M | 6.60M | 1.68M | 2.43M |
| Other Expenses | 200.00K | 0.00 | 91.00K | 84.00K |
| Operating Expenses | 14.21M | 11.61M | 4.45M | 6.45M |
| Cost & Expenses | 14.21M | 11.61M | 4.45M | 6.45M |
| Interest Income | 0.00 | 630.00 | 212.00 | 3.31K |
| Interest Expense | 1.08M | 630.00K | 212.00K | 3.31M |
| Depreciation & Amortization | 14.01M | 11.61M | 4.45M | 6.45M |
| EBITDA | -11.14M | -11.61M | 0.00 | 0.00 |
| EBITDA Ratio | 0.00% | 0.00% | 0.00% | 0.00% |
| Operating Income | -14.21M | -11.61M | -4.45M | -6.45M |
| Operating Income Ratio | 0.00% | 0.00% | 0.00% | 0.00% |
| Total Other Income/Expenses | -12.02M | -11.40M | -148.00K | 3.19M |
| Income Before Tax | -26.23M | -23.01M | -4.60M | -3.27M |
| Income Before Tax Ratio | 0.00% | 0.00% | 0.00% | 0.00% |
| Income Tax Expense | 0.00 | 1.00K | -1.00K | 9.00K |
| Net Income | -26.23M | -23.01M | -4.60M | -3.28M |
| Net Income Ratio | 0.00% | 0.00% | 0.00% | 0.00% |
| EPS | -30.29 | -70.16 | -15.90 | -27.15 |
| EPS Diluted | -30.26 | -70.07 | -15.87 | -27.15 |
| Weighted Avg Shares Out | 866.00K | 328.00K | 289.00K | 120.67K |
| Weighted Avg Shares Out (Dil) | 866.81K | 328.45K | 289.55K | 120.67K |
ICU LAWSUIT ALERT: Levi & Korsinsky Notifies SeaStar Medical Holding Corporation Investors of a Class Action Lawsuit and Upcoming Deadline
NEW YORK, NY / ACCESSWIRE / September 3, 2024 / If you suffered a loss on your SeaStar Medical Holding Corporation (NASDAQ:ICU) investment and want to learn about a potential recovery under the federal securities laws, follow the link below...
ICU Investors Have Opportunity to Lead SeaStar Medical Holding Corporation Securities Fraud Lawsuit
LOS ANGELES , Sept. 3, 2024 /PRNewswire/ -- The Law Offices of Frank R.
September 6, 2024 Deadline: Contact Levi & Korsinsky to Join Class Action Suit Against ICU
NEW YORK, NY / ACCESSWIRE / September 3, 2024 / If you suffered a loss on your SeaStar Medical Holding Corporation (NASDAQ:ICU) investment and want to learn about a potential recovery under the federal securities laws, follow the link below...
Levi & Korsinsky Notifies Shareholders of SeaStar Medical Holding Corporation (ICU) of a Class Action Lawsuit and an Upcoming Deadline
NEW YORK, NY / ACCESSWIRE / September 3, 2024 / If you suffered a loss on your SeaStar Medical Holding Corporation (NASDAQ:ICU) investment and want to learn about a potential recovery under the federal securities laws, follow the link below...
ICU DEADLINE: ROSEN, TOP RANKED NATIONAL INVESTOR ATTORNEYS, Encourages SeaStar Medical Holding Corporation Investors to Secure Counsel Before Important September 6 Deadline in Securities Class Action – ICU
NEW YORK, Sept. 03, 2024 (GLOBE NEWSWIRE) -- WHY: Rosen Law Firm, a global investor rights law firm, reminds purchasers of securities of SeaStar Medical Holding Corporation (NASDAQ: ICU, ICUCW) between October 31, 2022 and March 26, 2024, both dates...
SeaStar Medical Holding Corporation Sued for Securities Law Violations - Investors Should Contact Levi & Korsinsky for More Information - ICU
NEW YORK, NY / ACCESSWIRE / September 3, 2024 / If you suffered a loss on your SeaStar Medical Holding Corporation (NASDAQ:ICU) investment and want to learn about a potential recovery under the federal securities laws, follow the link below...
SeaStar Medical Holding Corporation May Have Violated Securities Laws And Affected Shareholders Are Invited To Contact The Schall Law Firm
LOS ANGELES, CA / ACCESSWIRE / September 3, 2024 / The Schall Law Firm, a national shareholder rights litigation firm, reminds investors of a class action lawsuit against SeaStar Medical Holding Corporation ("SeaStar" or "the Company") (NASDAQ:ICU) for violations of...
Shareholders that lost money on SeaStar Medical Holding Corporation (ICU) should contact Levi & Korsinsky about pending Class Action - ICU
NEW YORK, NY / ACCESSWIRE / September 3, 2024 / If you suffered a loss on your SeaStar Medical Holding Corporation (NASDAQ:ICU) investment and want to learn about a potential recovery under the federal securities laws, follow the link below...
ICU Investors Have Opportunity to Lead SeaStar Medical Holding Corporation Securities Fraud Lawsuit with the Schall Law Firm
LOS ANGELES, Sept. 03, 2024 (GLOBE NEWSWIRE) -- The Schall Law Firm , a national shareholder rights litigation firm, reminds investors of a class action lawsuit against SeaStar Medical Holding Corporation (“SeaStar” or “the Company”) (NASDAQ: ICU) for violations of...
Levi & Korsinsky Notifies Shareholders of SeaStar Medical Holding Corporation (ICU) of a Class Action Lawsuit and an Upcoming Deadline
NEW YORK, NY / ACCESSWIRE / September 3, 2024 / If you suffered a loss on your SeaStar Medical Holding Corporation (NASDAQ:ICU) investment and want to learn about a potential recovery under the federal securities laws, follow the link below...
Source: https://incomestatements.info
Category: Stock Reports